Global Platinum based Cancer Drug Market Growth 2025-2031

Global Platinum based Cancer Drug Market Growth 2025-2031

The global Platinum based Cancer Drug market size is predicted to grow from US$ 1590 million in 2025 to US$ 1877 million in 2031; it is expected to grow at a CAGR of 2.8% from 2025 to 2031.

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.

Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.

Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.

Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.

LP Information, Inc. (LPI) ' newest research report, the “Platinum based Cancer Drug Industry Forecast” looks at past sales and reviews total world Platinum based Cancer Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Platinum based Cancer Drug sales for 2025 through 2031. With Platinum based Cancer Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Platinum based Cancer Drug industry.

This Insight Report provides a comprehensive analysis of the global Platinum based Cancer Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Platinum based Cancer Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Platinum based Cancer Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Platinum based Cancer Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Platinum based Cancer Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Platinum based Cancer Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Cisplatin
Oxaliplatin
Carboplatin
Others

Segmentation by Application:
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Platinum based Cancer Drug market?

What factors are driving Platinum based Cancer Drug market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Platinum based Cancer Drug market opportunities vary by end market size?

How does Platinum based Cancer Drug break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.